Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus Harding

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|October 6, 2009
MAPK pathway activation delays G2/M progression by destabilizing Cdc25BPuji Astuti, Tanya Pike, Charlotte Widberg, et al.
Nature Cell Biology|July 10, 2007
Plasma membrane nanoswitches generate high-fidelity Ras signal transductionTianhai Tian, Angus Harding, Kerry Inder, et al.
Molecular Biology of the Cell|September 12, 2008
Activation of the MAPK module from different spatial locations generates distinct system outputsKerry Inder, Angus Harding, Sarah J Plowman, et al.
The Journal of Biological Chemistry|January 11, 2005
Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathwayMegan A Maxwell, Mark E Cleasby, Angus Harding, et al.
Molecular and Cellular Biology|January 14, 2009
The mitogen-activated protein kinase scaffold KSR1 is required for recruitment of extracellular signal-regulated kinase to the immunological synapseEmanuele Giurisato, Joseph Lin, Angus Harding, et al.
Molecular Biosystems|January 23, 2014
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumorsPrudence Donovan, Kathleen Cato, Roxane Legaie, et al.
Molecular Cancer Therapeutics|July 10, 2012
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
Brain : a Journal of Neurology|April 26, 2011
Evidence for label-retaining tumour-initiating cells in human glioblastomaLoic P Deleyrolle, Angus Harding, Kathleen Cato, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|October 6, 2009
MAPK pathway activation delays G2/M progression by destabilizing Cdc25BPuji Astuti, Tanya Pike, Charlotte Widberg, et al.
Nature Cell Biology|July 10, 2007
Plasma membrane nanoswitches generate high-fidelity Ras signal transductionTianhai Tian, Angus Harding, Kerry Inder, et al.
Molecular Biology of the Cell|September 12, 2008
Activation of the MAPK module from different spatial locations generates distinct system outputsKerry Inder, Angus Harding, Sarah J Plowman, et al.
The Journal of Biological Chemistry|January 11, 2005
Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathwayMegan A Maxwell, Mark E Cleasby, Angus Harding, et al.
Molecular and Cellular Biology|January 14, 2009
The mitogen-activated protein kinase scaffold KSR1 is required for recruitment of extracellular signal-regulated kinase to the immunological synapseEmanuele Giurisato, Joseph Lin, Angus Harding, et al.
Molecular Biosystems|January 23, 2014
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumorsPrudence Donovan, Kathleen Cato, Roxane Legaie, et al.
Molecular Cancer Therapeutics|July 10, 2012
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
Brain : a Journal of Neurology|April 26, 2011
Evidence for label-retaining tumour-initiating cells in human glioblastomaLoic P Deleyrolle, Angus Harding, Kathleen Cato, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 2